After finishing at $2.91 in the prior trading day, Adaptive Biotechnologies Corp (NASDAQ: ADPT) closed at $2.75, down -5.50%. On the day, 1605666 shares were traded.
Ratios:
Our goal is to gain a better understanding of ADPT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.50 and its Current Ratio is at 4.66. In the meantime, Its Debt-to-Equity ratio is 0.74 whereas as Long-Term Debt/Eq ratio is at 0.71.
On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $15.
Piper Sandler Upgraded its Neutral to Overweight on December 21, 2022, whereas the target price for the stock was revised from $7.50 to $14.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 05 ’24 when ROBINS CHAD M sold 48,673 shares for $3.43 per share. The transaction valued at 167,007 led to the insider holds 2,576,701 shares of the business.
RUBINSTEIN JULIE sold 39,070 shares of ADPT for $135,764 on Mar 05 ’24. The President now owns 472,754 shares after completing the transaction at $3.47 per share. On Mar 05 ’24, another insider, BENZENO SHARON, who serves as the Chief Commercial Ofc Imm Med of the company, sold 29,390 shares for $3.44 each. As a result, the insider received 100,994 and left with 327,415 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.34 while its Price-to-Book (P/B) ratio in mrq is 1.29.
Stock Price History:
Over the past 52 weeks, ADPT has reached a high of $9.08, while it has fallen to a 52-week low of $2.53.
Shares Statistics:
A total of 145.08M shares are outstanding, with a floating share count of 138.51M. Insiders hold about 4.54% of the company’s shares, while institutions hold 95.42% stake in the company.
Earnings Estimates
Its stock is currently analyzed by Automatic Data Processing, Inc. different market analysts. The consensus estimate for the next quarter is $6.16, with high estimates of $28.64 and low estimates of $7.76.
Analysts are recommending an EPS of between $Consumer Cyclical and $Technology for the fiscal current year, implying an average EPS of $Industrials.
